Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA with Daratumumab, Pomalidomide, and Dexamethasone in Multiple Myeloma
NCT04700176Phase 2Terminated
- Sponsor
- Hackensack Meridian Health
- Start
- May 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in multiple myeloma (MM), sponsored by Hackensack Meridian Health. Started May 2022; status: terminated.
02
Drugs
tretinoin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04700176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700176.